From biomarker identification and epigenetic analysis, to tumor response and tumor immunogenicity determination, advances in genomic technologies, like next-generation sequencing, are helping advance our understanding of interactions between the immune system and cancer, guiding therapeutic development. To learn more please visit the Illumina website

Interested in reading more?

The Scientist ARCHIVES

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?